A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Clinical trial NCT04965675 · RECRUITING
Trial details
- NCT number
- NCT04965675
- Sponsor
- H. Lundbeck A/S
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2026-09-05
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.